⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Marshall GlesbyM.D.

Infectious Disease · New York, NY 10021

NPI: 1396891644

Share:

33

🟠 Elevated

Risk Flags

High opioid rate vs specialty peersExtreme cost outlier (population + peer)High long-acting opioid rate vs peersExtreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

709

Total Claims

$741K

Drug Cost

18

Beneficiaries

$41K

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+10
Cost per patient outlier+10
Long-acting opioid rate+8
High fills per patient+5

Score components are additive. Read full methodology

Peer Comparison vs. 5,387 Infectious Disease providers

+414%

Cost per patient vs peers

$41K vs $8,010 avg

+94%

Brand preference vs peers

41.3% vs 21.3% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

5.1%

Opioid Rate

36

Opioid Claims

$6,573

Opioid Cost

41.7%

Long-Acting Rate

Brand vs Generic

59% generic

Brand: 293 claims · $641K

Generic: 416 claims · $100K

Patient Profile

63

Avg Age

Female

1.19

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About